aTYR PHARMA INC — Director's Dealing 2016

Sep 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: aTYR PHARMA INC (LIFE)
CIK: 0001339970
Period of Report: 2016-09-13

Reporting Person: Cubitt Andrew (VP, Product Protection)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-13	Employee Stock Option (right to buy)	$3.06	A	25000	Acquired	2026-09-13	Common Stock (25000)	Direct

Footnotes

F1: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning October 13, 2016, such that this option will be fully exercisable on September 13, 2020. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.